The risk or severity of adverse effects can be increased when chlorprothixene is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with haloperidol.


The risk or severity of adverse effects can be increased when meperidine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when prazosin is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when bromazepam is combined with trazodone.


The risk or severity of adverse effects can be increased when methysergide is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when methysergide is combined with pravastatin.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Masoprocol.


The risk or severity of adverse effects can be increased when Phenelzine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when tubocurarine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Rufinamide is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Valganciclovir is combined with stavudine.


The risk or severity of adverse effects can be increased when codeine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when suprofen is combined with Propacetamol.


The risk or severity of adverse effects can be increased when antipyrine is combined with Halobetasol.


The risk or severity of adverse effects can be increased when zonisamide is combined with Retigabine.


The risk or severity of adverse effects can be increased when paramethasone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when antipyrine is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when HEROIN is combined with Perospirone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with trandolapril.


The risk or severity of adverse effects can be increased when pentoxifylline is combined with mesalamine.


The risk or severity of adverse effects can be increased when Limaprost is combined with Treprostinil.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with baclofen.


The risk or severity of adverse effects can be increased when Articaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when dapsone is combined with prilocaine.


The risk or severity of adverse effects can be increased when benazepril is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Asenapine.


The risk or severity of adverse effects can be increased when efavirenz is combined with ethanol.


The risk or severity of adverse effects can be increased when midazolam is combined with thiamylal.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with azelastine.


The risk or severity of adverse effects can be increased when Halazepam is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when bromocriptine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when metronidazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Melatonin is combined with methocarbamol.


The risk or severity of adverse effects can be increased when thioridazine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Melatonin is combined with triprolidine.


The risk or severity of adverse effects can be increased when furazolidone is combined with Bambuterol.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Mometasone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with clidinium.


The risk or severity of adverse effects can be increased when mesalamine is combined with difluprednate.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Efonidipine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Lacidipine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Benidipine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when morphine is combined with clonazepam.


The risk or severity of adverse effects can be increased when morphine is combined with promethazine.


The risk or severity of adverse effects can be increased when felodipine is combined with cilazapril.


The risk or severity of adverse effects can be increased when morphine is combined with Melatonin.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with quetiapine.


The risk or severity of adverse effects can be increased when cetirizine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when diazepam is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Telmisartan is combined with aspirin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when selegiline is combined with Asenapine.


The risk or severity of adverse effects can be increased when buspirone is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with pimozide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with triamterene.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when buspirone is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when efavirenz is combined with Olopatadine.


The risk or severity of adverse effects can be increased when buspirone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when estrone is combined with galanthamine.


The risk or severity of adverse effects can be increased when indomethacin is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when estrone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when alprazolam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with oxymorphone.


The risk or severity of adverse effects can be increased when alprazolam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Clofarabine is combined with papaverine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with zopiclone.


The risk or severity of adverse effects can be increased when oxazepam is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with edrophonium.


The risk or severity of adverse effects can be increased when atenolol is combined with Riociguat.


The risk or severity of adverse effects can be increased when olanzapine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when meperidine is combined with brotizolam.


The risk or severity of adverse effects can be increased when metaproterenol is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when Clobetasone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with ticlopidine.


The risk or severity of adverse effects can be increased when eperisone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when SOMATOSTATIN is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when losartan is combined with nifedipine.


The risk or severity of adverse effects can be increased when ganciclovir is combined with didanosine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when losartan is combined with papaverine.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Clevidipine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with isradipine.


The risk or severity of adverse effects can be increased when HEROIN is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when prilocaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when protriptyline is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when hexetidine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when benztropine is combined with Trospium.


The risk or severity of adverse effects can be increased when nadolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when 6-Mercaptopurine is combined with leflunomide.


The risk or severity of adverse effects can be increased when amphotericin b is combined with metoprolol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with ropinirole.


The risk or severity of adverse effects can be increased when chlormezanone is combined with felbamate.


The risk or severity of adverse effects can be increased when HEROIN is combined with indapamide.


The risk or severity of adverse effects can be increased when Masoprocol is combined with ibuprofen.


The risk or severity of adverse effects can be increased when phenytoin is combined with meclizine.


The risk or severity of adverse effects can be increased when dexamethasone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when trazodone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when dexamethasone is combined with memantine.


The risk or severity of adverse effects can be increased when SAQUINAVIR is combined with efavirenz.


The risk or severity of adverse effects can be increased when butamben is combined with efavirenz.


The risk or severity of adverse effects can be increased when oxymorphone is combined with rasagiline.


The risk or severity of adverse effects can be increased when terconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when quazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when ibuprofen is combined with flumethasone.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Spectinomycin.


The risk or severity of adverse effects can be increased when proparacaine is combined with Butethal.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when prilocaine is combined with Halazepam.


The risk or severity of adverse effects can be increased when halothane is combined with tretinoin.


The risk or severity of adverse effects can be increased when alprazolam is combined with Normethadone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when isoflurane is combined with Lurasidone.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Phenelzine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when cinnarizine is combined with pravastatin.


The risk or severity of adverse effects can be increased when enflurane is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when amobarbital is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with vigabatrin.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with acebutolol.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with captopril.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with selegiline.


The risk or severity of adverse effects can be increased when reserpine is combined with Articaine.


The risk or severity of adverse effects can be increased when tiapride is combined with baclofen.


The risk or severity of adverse effects can be increased when moclobemide is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Clevidipine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with quinidine.


The risk or severity of adverse effects can be increased when diazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with malathion.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when meperidine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when reserpine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when cetirizine is combined with clonidine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with diazoxide.


The risk or severity of adverse effects can be increased when carprofen is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with clomipramine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with cilazapril.


The risk or severity of adverse effects can be increased when azelastine is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when disulfiram is combined with isoniazid.


The risk or severity of adverse effects can be increased when amphotericin b is combined with carvedilol.


The risk or severity of adverse effects can be increased when lorazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Escitalopram.


The risk or severity of adverse effects can be increased when methysergide is combined with Repaglinide.


The risk or severity of adverse effects can be increased when butalbital is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Rufinamide is combined with clidinium.


The risk or severity of adverse effects can be increased when secobarbital is combined with Flibanserin.


The risk or severity of adverse effects can be increased when pentazocine is combined with tiagabine.


The risk or severity of adverse effects can be increased when rapamycin is combined with nitrendipine.


The risk or severity of adverse effects can be increased when oxycodone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when oxycodone is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Almotriptan is combined with rizatriptan.


The risk or severity of adverse effects can be increased when Almotriptan is combined with naratriptan.


The risk or severity of adverse effects can be increased when oxycodone is combined with sevoflurane.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Desloratadine.


The risk or severity of adverse effects can be increased when oxycodone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when docetaxel is combined with Vapreotide.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Apremilast.


The risk or severity of adverse effects can be increased when furosemide is combined with bumetanide.


The risk or severity of adverse effects can be increased when azelastine is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when oxycodone is combined with baclofen.


The risk or severity of adverse effects can be increased when furosemide is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when azelastine is combined with Halobetasol.


The risk or severity of adverse effects can be increased when furosemide is combined with quinapril.


The risk or severity of adverse effects can be increased when furosemide is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when desoximetasone is combined with enoxacin.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when rasagiline is combined with quetiapine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with raloxifene.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with ethotoin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with penbutolol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when trazodone is combined with doxepin.


The risk or severity of adverse effects can be increased when temazepam is combined with diazepam.


The risk or severity of adverse effects can be increased when leflunomide is combined with Mometasone.


The risk or severity of adverse effects can be increased when oxycodone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when oxycodone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Bretylium.


The risk or severity of adverse effects can be increased when Naftifine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when nabumetone is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when oxycodone is combined with quazepam.


The risk or severity of adverse effects can be increased when oxycodone is combined with prazepam.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Salsalate is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Bortezomib is combined with isoflurane.


The risk or severity of adverse effects can be increased when propofol is combined with diazepam.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with citalopram.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with LYCOPENE.


The risk or severity of adverse effects can be increased when isoflurane is combined with fexofenadine.


The risk or severity of adverse effects can be increased when morphine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when gabapentin is combined with desipramine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when nimesulide is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when estazolam is combined with dantrolene.


The risk or severity of adverse effects can be increased when cilnidipine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when timolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Propacetamol.


The risk or severity of adverse effects can be increased when tetracaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when niflumic acid is combined with nimesulide.


The risk or severity of adverse effects can be increased when aspirin is combined with oxaprozin.


The risk or severity of adverse effects can be increased when amoxapine is combined with scopolamine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when procarbazine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when tetracaine is combined with doxepin.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with estrone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when nimesulide is combined with medrysone.


The risk or severity of adverse effects can be increased when prilocaine is combined with levodopa.


The risk or severity of adverse effects can be increased when mesoridazine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with tiapride.


The risk or severity of adverse effects can be increased when Varenicline is combined with ethanol.


The risk or severity of adverse effects can be increased when apomorphine is combined with Clofarabine.


The risk or severity of adverse effects can be increased when codeine is combined with Alvimopan.


The risk or severity of adverse effects can be increased when apomorphine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when methysergide is combined with DALFOPRISTIN.


The risk or severity of adverse effects can be increased when imipramine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when doxepin is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when Fospropofol is combined with brotizolam.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with memantine.


The risk or severity of adverse effects can be increased when aspirin is combined with flumethasone.


The risk or severity of adverse effects can be increased when azelastine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when clonidine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when hydromorphone is combined with loratadine.


The risk or severity of adverse effects can be increased when trandolapril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Nabilone is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Fospropofol is combined with meclizine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with mesoridazine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with maprotiline.


The risk or severity of adverse effects can be increased when Nabilone is combined with furosemide.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with carvedilol.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when tolnaftate is combined with Pinaverium.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when prilocaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with lithium ion.


The risk or severity of adverse effects can be increased when Miltefosine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with loxapine.


The risk or severity of adverse effects can be increased when Alogliptin is combined with cilazapril.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Carbetocin is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Alogliptin is combined with Spirapril.


The risk or severity of adverse effects can be increased when alclofenac is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with tetracaine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with etizolam.


The risk or severity of adverse effects can be increased when indapamide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Olopatadine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with thioridazine.


The risk or severity of adverse effects can be increased when resveratrol is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when procyclidine is combined with morphine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mometasone.


The risk or severity of adverse effects can be increased when sulpiride is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when thiamylal is combined with citalopram.


The risk or severity of adverse effects can be increased when methadone is combined with Butethal.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when erythromycin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when Articaine is combined with clidinium.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with metoprolol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Perospirone.


The risk or severity of adverse effects can be increased when haloperidol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when haloperidol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when nabumetone is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Melatonin is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when nilvadipine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Melatonin is combined with glutethimide.


The risk or severity of adverse effects can be increased when midazolam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with cetirizine.


The risk or severity of adverse effects can be increased when tropicamide is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Almotriptan is combined with metoclopramide.


The risk or severity of adverse effects can be increased when temazepam is combined with oxycodone.


The risk or severity of adverse effects can be increased when pentazocine is combined with butamben.


The risk or severity of adverse effects can be increased when Almotriptan is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with clonazepam.


The risk or severity of adverse effects can be increased when midazolam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when scopolamine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Alogliptin is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when methadone is combined with maprotiline.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with protriptyline.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when buspirone is combined with Articaine.


The risk or severity of adverse effects can be increased when lisinopril is combined with methyldopa.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Normethadone.


The risk or severity of adverse effects can be increased when buspirone is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Normethadone is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when celecoxib is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when miconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when temazepam is combined with HEROIN.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with protriptyline.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with flunisolide.


The risk or severity of adverse effects can be increased when NEOSTIGMINE is combined with methacholine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with acetazolamide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Micafungin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when rapamycin is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when fosinopril is combined with diclofenac.


The risk or severity of adverse effects can be increased when fosinopril is combined with enalapril.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when azelastine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with labetalol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with citalopram.


The risk or severity of adverse effects can be increased when amiodarone is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when Torasemide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when griseofulvin is combined with nifedipine.


The risk or severity of adverse effects can be increased when desipramine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when ethopropazine is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when phenobarbital is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when ketoconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when Butoconazole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when clidinium is combined with Milnacipran.


The risk or severity of adverse effects can be increased when trandolapril is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when ropinirole is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with metoprolol.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with baclofen.


The risk or severity of adverse effects can be increased when rasagiline is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Metipranolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when caffeine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when procaine is combined with Melatonin.


The risk or severity of adverse effects can be increased when Micafungin is combined with nilvadipine.


The risk or severity of adverse effects can be increased when trimeprazine is combined with amoxapine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when butabarbital is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when zaleplon is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when procaine is combined with promethazine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Tolcapone.


The risk or severity of adverse effects can be increased when temazepam is combined with hydromorphone.


The risk or severity of adverse effects can be increased when temazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when temazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Masoprocol is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with ethotoin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Salsalate is combined with dexamethasone.


The risk or severity of adverse effects can be increased when apomorphine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when naratriptan is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Metixene.


The risk or severity of adverse effects can be increased when Remoxipride is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with HEROIN.


The risk or severity of adverse effects can be increased when codeine is combined with bromazepam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when codeine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when cilazapril is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when pentobarbital is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when haloperidol is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with sumatriptan.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with tizanidine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with quinapril.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with methylene blue.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Toloxatone.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Pirlindole.


The risk or severity of adverse effects can be increased when amobarbital is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with butamben.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when amobarbital is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when quinidine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with carvedilol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with phenobarbital.


The risk or severity of adverse effects can be increased when Conivaptan is combined with ILOPROST.


The risk or severity of adverse effects can be increased when suprofen is combined with acemetacin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with edrophonium.


The risk or severity of adverse effects can be increased when ketamine is combined with brotizolam.


The risk or severity of adverse effects can be increased when quinapril is combined with meperidine.


The risk or severity of adverse effects can be increased when captopril is combined with meperidine.


The risk or severity of adverse effects can be increased when Etomidate is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when propantheline is combined with tubocurarine.


The risk or severity of adverse effects can be increased when ropinirole is combined with Bretylium.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with doxepin.


The risk or severity of adverse effects can be increased when halothane is combined with glutethimide.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when ramipril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when halothane is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with meclizine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Agomelatine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with spironolactone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with triprolidine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with dibucaine.


The risk or severity of adverse effects can be increased when ketamine is combined with trimipramine.


The risk or severity of adverse effects can be increased when ketamine is combined with procaine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when propofol is combined with prazosin.


The risk or severity of adverse effects can be increased when propofol is combined with loratadine.


The risk or severity of adverse effects can be increased when Salsalate is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Nepafenac is combined with fenoprofen.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with alclofenac.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Toloxatone is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when isoflurane is combined with hydralazine.


The risk or severity of adverse effects can be increased when citalopram is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when Darunavir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when bupropion is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with enoxacin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when phenylephrine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when miconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with galanthamine.


The risk or severity of adverse effects can be increased when felbamate is combined with Milnacipran.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with triamterene.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with loratadine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Retigabine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with imipramine.


The risk or severity of adverse effects can be increased when ketamine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when citalopram is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ramipril is combined with sotalol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with trazodone.


The risk or severity of adverse effects can be increased when ramipril is combined with celecoxib.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when dyclonine is combined with butalbital.


The risk or severity of adverse effects can be increased when phenobarbital is combined with zotepine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when bromazepam is combined with dyclonine.


The risk or severity of adverse effects can be increased when Vecuronium is combined with methadone.


The risk or severity of adverse effects can be increased when bromazepam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when butenafine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when methscopolamine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when metolazone is combined with terazosin.


The risk or severity of adverse effects can be increased when D-mannitol is combined with captopril.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Drospirenone.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with promethazine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when D-mannitol is combined with acebutolol.


The risk or severity of adverse effects can be increased when clonidine is combined with irbesartan.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with tolazoline.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with maprotiline.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Tramadol is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when triamcinolone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when glutethimide is combined with fludiazepam.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with promethazine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with clonazepam.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when epinephrine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with carprofen.


The risk or severity of adverse effects can be increased when estrone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when halothane is combined with scopolamine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with promethazine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with clonazepam.


The risk or severity of adverse effects can be increased when halothane is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Phenelzine is combined with reserpine.


The risk or severity of adverse effects can be increased when brotizolam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Desloratadine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when epoprostenol is combined with propofol.


The risk or severity of adverse effects can be increased when Desloratadine is combined with flunarizine.


The risk or severity of adverse effects can be increased when estazolam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when estazolam is combined with benzocaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Difenoxin.


The risk or severity of adverse effects can be increased when nisoldipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when benzocaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when thioridazine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Agomelatine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when quetiapine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when meperidine is combined with maprotiline.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when epinastine is combined with diflunisal.


The risk or severity of adverse effects can be increased when estrone is combined with memantine.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Olmesartan.


The risk or severity of adverse effects can be increased when nisoldipine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with efavirenz.


The risk or severity of adverse effects can be increased when clorazepate is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when tretinoin is combined with minoxidil.


The risk or severity of adverse effects can be increased when nisoldipine is combined with quinapril.


The risk or severity of adverse effects can be increased when phentolamine is combined with nifedipine.


The risk or severity of adverse effects can be increased when suprofen is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Propacetamol.


The risk or severity of adverse effects can be increased when butabarbital is combined with gabapentin.


The risk or severity of adverse effects can be increased when estazolam is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with irbesartan.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when clomipramine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with diflorasone.


The risk or severity of adverse effects can be increased when propofol is combined with zotepine.


The risk or severity of adverse effects can be increased when propofol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when loratadine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when dyclonine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when celecoxib is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when nalbuphine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when estradiol is combined with Ospemifene.


The risk or severity of adverse effects can be increased when celecoxib is combined with amcinonide.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with nimesulide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Normethadone.


The risk or severity of adverse effects can be increased when diclofenac is combined with mesalamine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when diclofenac is combined with alclometasone.


The risk or severity of adverse effects can be increased when apomorphine is combined with ramipril.


The risk or severity of adverse effects can be increased when apomorphine is combined with valsartan.


The risk or severity of adverse effects can be increased when leflunomide is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Rotigotine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when enflurane is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Rotigotine is combined with tolazoline.


The risk or severity of adverse effects can be increased when dibucaine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with ambenonium.


The risk or severity of adverse effects can be increased when miconazole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when perphenazine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when eperisone is combined with lovastatin.


The risk or severity of adverse effects can be increased when celecoxib is combined with Olopatadine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with butalbital.


The risk or severity of adverse effects can be increased when pentobarbital is combined with METAXALONE.


The risk or severity of adverse effects can be increased when temazepam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when meperidine is combined with zonisamide.


The risk or severity of adverse effects can be increased when glutethimide is combined with brotizolam.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when meperidine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when gabapentin is combined with citalopram.


The risk or severity of adverse effects can be increased when meperidine is combined with tiagabine.


The risk or severity of adverse effects can be increased when ropinirole is combined with bumetanide.


The risk or severity of adverse effects can be increased when fexofenadine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when gabapentin is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when griseofulvin is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when captopril is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when triflupromazine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Tramadol is combined with clidinium.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when ropinirole is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Trospium is combined with Tramadol.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with diclofenac.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Propiverine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with niflumic acid.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Retigabine.


The risk or severity of adverse effects can be increased when methylene blue is combined with Salmeterol.


The risk or severity of adverse effects can be increased when ethopropazine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with terazosin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Etidocaine.


The risk or severity of adverse effects can be increased when benzocaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when clozapine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with equilin.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with sevoflurane.


The risk or severity of adverse effects can be increased when rescinnamine is combined with resveratrol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Butethal is combined with brotizolam.


The risk or severity of adverse effects can be increased when amiodarone is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when amobarbital is combined with meclizine.


The risk or severity of adverse effects can be increased when morphine is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when thioridazine is combined with cilazapril.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with atenolol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Etidocaine.


The risk or severity of adverse effects can be increased when procyclidine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when butamben is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when triflupromazine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when triflupromazine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when celecoxib is combined with prilocaine.


The risk or severity of adverse effects can be increased when METYROSINE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when selegiline is combined with olanzapine.


The risk or severity of adverse effects can be increased when selegiline is combined with atenolol.


The risk or severity of adverse effects can be increased when pentazocine is combined with estazolam.


The risk or severity of adverse effects can be increased when Sacubitril is combined with leflunomide.


The risk or severity of adverse effects can be increased when PARALDEHYDE is combined with nefazodone.


The risk or severity of adverse effects can be increased when enalapril is combined with methazolamide.


The risk or severity of adverse effects can be increased when selegiline is combined with methadone.


The risk or severity of adverse effects can be increased when tolnaftate is combined with bepridil.


The risk or severity of adverse effects can be increased when cetirizine is combined with clidinium.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Etidocaine.


The risk or severity of adverse effects can be increased when pentazocine is combined with dantrolene.


The risk or severity of adverse effects can be increased when minoxidil is combined with bumetanide.


The risk or severity of adverse effects can be increased when butabarbital is combined with ketamine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Nabilone.


The risk or severity of adverse effects can be increased when temazepam is combined with halothane.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with brimonidine.


The risk or severity of adverse effects can be increased when zopiclone is combined with clidinium.


The risk or severity of adverse effects can be increased when temazepam is combined with thiamylal.


The risk or severity of adverse effects can be increased when sulindac is combined with nimesulide.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with sotalol.


The risk or severity of adverse effects can be increased when temazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when triprolidine is combined with efavirenz.


The risk or severity of adverse effects can be increased when bromopride is combined with sulpiride.


The risk or severity of adverse effects can be increased when bumetanide is combined with Arbekacin.


The risk or severity of adverse effects can be increased when clorazepate is combined with carisoprodol.


The risk or severity of adverse effects can be increased when sulindac is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when clorazepate is combined with sulpiride.


The risk or severity of adverse effects can be increased when Suvorexant is combined with sertraline.


The risk or severity of adverse effects can be increased when risperidone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when benazepril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when risperidone is combined with tiapride.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with quetiapine.


The risk or severity of adverse effects can be increased when Trospium is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with triprolidine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with methocarbamol.


The risk or severity of adverse effects can be increased when epirizole is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with sertraline.


The risk or severity of adverse effects can be increased when epirizole is combined with paramethasone.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with nicardipine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with tolmetin.


The risk or severity of adverse effects can be increased when gabapentin is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when quazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when midodrine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when thioridazine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Metipranolol.


The risk or severity of adverse effects can be increased when thioridazine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when benazepril is combined with dipyridamole.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with scopolamine.


The risk or severity of adverse effects can be increased when tretinoin is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Apremilast.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with D-mannitol.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Difenoxin.


The risk or severity of adverse effects can be increased when butorphanol is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when irbesartan is combined with epirizole.


The risk or severity of adverse effects can be increased when butorphanol is combined with glutethimide.


The risk or severity of adverse effects can be increased when pergolide is combined with efavirenz.


The risk or severity of adverse effects can be increased when pergolide is combined with testosterone.


The risk or severity of adverse effects can be increased when pergolide is combined with nicardipine.


The risk or severity of adverse effects can be increased when pimozide is combined with mesoridazine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with clonazepam.


The risk or severity of adverse effects can be increased when trimetrexate is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when reserpine is combined with gabapentin.


The risk or severity of adverse effects can be increased when trimetrexate is combined with Efonidipine.


The risk or severity of adverse effects can be increased when trimetrexate is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Propiverine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when butabarbital is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when reserpine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when lithium ion is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Olopatadine.


The risk or severity of adverse effects can be increased when promazine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with rasagiline.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Propacetamol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with methylergonovine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when maprotiline is combined with Retigabine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with mefloquine.


The risk or severity of adverse effects can be increased when terazosin is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when nisoldipine is combined with indapamide.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with furosemide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with sulpiride.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with tizanidine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Masoprocol.


The risk or severity of adverse effects can be increased when amoxapine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when Clofarabine is combined with isradipine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when chloroxine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when resveratrol is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when resveratrol is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Pentolinium is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when sulpiride is combined with doxepin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with benzocaine.


The risk or severity of adverse effects can be increased when selegiline is combined with Escitalopram.


The risk or severity of adverse effects can be increased when bromazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when selegiline is combined with moclobemide.


The risk or severity of adverse effects can be increased when propranolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with felbamate.


The risk or severity of adverse effects can be increased when Triflusal is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when prazosin is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with citalopram.


The risk or severity of adverse effects can be increased when barnidipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with midazolam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Ramelteon is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when meperidine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when sulindac is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when ketamine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with levorphanol.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with theobromine.


The risk or severity of adverse effects can be increased when reserpine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when reserpine is combined with irbesartan.


The risk or severity of adverse effects can be increased when Apremilast is combined with DESONIDE.


The risk or severity of adverse effects can be increased when meprobamate is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Eplerenone is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when olanzapine is combined with benzocaine.


The risk or severity of adverse effects can be increased when reserpine is combined with felodipine.


The risk or severity of adverse effects can be increased when reserpine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when cabergoline is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when olanzapine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when olanzapine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when reserpine is combined with meprobamate.


The risk or severity of adverse effects can be increased when celecoxib is combined with oxaprozin.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Pipamperone.


The risk or severity of adverse effects can be increased when estazolam is combined with efavirenz.


The risk or severity of adverse effects can be increased when buspirone is combined with enflurane.


The risk or severity of adverse effects can be increased when Fospropofol is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Fospropofol is combined with clemastine.


The risk or severity of adverse effects can be increased when piracetam is combined with liothyronine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with oxprenolol.


The risk or severity of adverse effects can be increased when MELPERONE is combined with zotepine.


The risk or severity of adverse effects can be increased when promazine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with PRIMAQUINE.


The risk or severity of adverse effects can be increased when promazine is combined with ethotoin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with sulpiride.


The risk or severity of adverse effects can be increased when aspirin is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with phenytoin.


The risk or severity of adverse effects can be increased when ketamine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when aspirin is combined with haloperidol.


The risk or severity of adverse effects can be increased when loteprednol is combined with decamethonium.


The risk or severity of adverse effects can be increased when lorazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when resveratrol is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Paliperidone is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Melatonin is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Melatonin is combined with amitriptyline.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when enalapril is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when enalapril is combined with quinapril.


The risk or severity of adverse effects can be increased when enalapril is combined with bumetanide.


The risk or severity of adverse effects can be increased when perphenazine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when haloperidol is combined with butorphanol.


The risk or severity of adverse effects can be increased when nabumetone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when perphenazine is combined with baclofen.


The risk or severity of adverse effects can be increased when diazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with celecoxib.


The risk or severity of adverse effects can be increased when Pipamperone is combined with desipramine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when fosinopril is combined with cilazapril.


The risk or severity of adverse effects can be increased when haloperidol is combined with fludiazepam.


The risk or severity of adverse effects can be increased when tropicamide is combined with cyclopentolate.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Bretylium.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with HEROIN.


The risk or severity of adverse effects can be increased when trazodone is combined with tiapride.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when imipramine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when buspirone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when meprobamate is combined with oxazepam.


The risk or severity of adverse effects can be increased when meprobamate is combined with nalbuphine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when meprobamate is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when olanzapine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Melatonin is combined with Normethadone.


The risk or severity of adverse effects can be increased when Flibanserin is combined with Escitalopram.


The risk or severity of adverse effects can be increased when olanzapine is combined with prilocaine.


The risk or severity of adverse effects can be increased when perphenazine is combined with loratadine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Iloperidone.


The risk or severity of adverse effects can be increased when epoprostenol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when morphine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when methysergide is combined with methazolamide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with fosinopril.


The risk or severity of adverse effects can be increased when clidinium is combined with desipramine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with triflupromazine.


The risk or severity of adverse effects can be increased when valsartan is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when methysergide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when methysergide is combined with mequitazine.


The risk or severity of adverse effects can be increased when methysergide is combined with Atazanavir.


The risk or severity of adverse effects can be increased when methadone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Melatonin is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when thalidomide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with zopiclone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when ropinirole is combined with Eplerenone.


The risk or severity of adverse effects can be increased when lisinopril is combined with D-mannitol.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with D-mannitol.


The risk or severity of adverse effects can be increased when methadone is combined with tiagabine.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with furosemide.


The risk or severity of adverse effects can be increased when enalapril is combined with leflunomide.


The risk or severity of adverse effects can be increased when oxycodone is combined with diazepam.


The risk or severity of adverse effects can be increased when Clevidipine is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when Micafungin is combined with felodipine.


The risk or severity of adverse effects can be increased when enflurane is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when alprazolam is combined with etizolam.


The risk or severity of adverse effects can be increased when barnidipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when phenindione is combined with Deferasirox.


The risk or severity of adverse effects can be increased when carisoprodol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when zonisamide is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when zaleplon is combined with Articaine.


The risk or severity of adverse effects can be increased when proparacaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Articaine.


The risk or severity of adverse effects can be increased when dapsone is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when Spirapril is combined with suprofen.


The risk or severity of adverse effects can be increased when morphine is combined with dantrolene.


The risk or severity of adverse effects can be increased when benazepril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when morphine is combined with estazolam.


The risk or severity of adverse effects can be increased when morphine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when rasagiline is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when ethotoin is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when proparacaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when resveratrol is combined with niflumic acid.


The risk or severity of adverse effects can be increased when terazosin is combined with captopril.


The risk or severity of adverse effects can be increased when lorazepam is combined with oxazepam.


The risk or severity of adverse effects can be increased when pramipexole is combined with selegiline.


The risk or severity of adverse effects can be increased when Aluminium hydroxide is combined with misoprostol.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when procaine is combined with imipramine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when sulindac is combined with Deferasirox.


The risk or severity of adverse effects can be increased when methylergonovine is combined with risperidone.


The risk or severity of adverse effects can be increased when Propacetamol is combined with flumethasone.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with medrysone.


The risk or severity of adverse effects can be increased when pramipexole is combined with ramipril.


The risk or severity of adverse effects can be increased when duloxetine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when LISURIDE is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with paramethasone.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with barnidipine.


The risk or severity of adverse effects can be increased when flurazepam is combined with enflurane.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with metoclopramide.


The risk or severity of adverse effects can be increased when etizolam is combined with trimipramine.


The risk or severity of adverse effects can be increased when tiapride is combined with carisoprodol.


The risk or severity of adverse effects can be increased when tiapride is combined with sulpiride.


The risk or severity of adverse effects can be increased when oxycodone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with epinastine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with zolmitriptan.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with tiagabine.


The risk or severity of adverse effects can be increased when cilostazol is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Propacetamol is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Butethal is combined with clomipramine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with methylene blue.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Toloxatone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Pirlindole.


The risk or severity of adverse effects can be increased when stavudine is combined with didanosine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with duloxetine.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Metixene.


The risk or severity of adverse effects can be increased when metoclopramide is combined with fluoxetine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Normethadone.


The risk or severity of adverse effects can be increased when nicardipine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Desloratadine.


The risk or severity of adverse effects can be increased when nicardipine is combined with furosemide.


The risk or severity of adverse effects can be increased when nicardipine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Lumefantrine is combined with dapsone.


The risk or severity of adverse effects can be increased when phenytoin is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Asenapine is combined with butalbital.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Agomelatine is combined with butamben.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with cilazapril.


The risk or severity of adverse effects can be increased when proparacaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when indomethacin is combined with acemetacin.


The risk or severity of adverse effects can be increased when Nilotinib is combined with clozapine.


The risk or severity of adverse effects can be increased when proparacaine is combined with doxepin.


The risk or severity of adverse effects can be increased when diazepam is combined with halothane.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when furazolidone is combined with Salmeterol.


The risk or severity of adverse effects can be increased when papaverine is combined with penbutolol.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Retigabine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when nimodipine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Paliperidone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when citalopram is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when diazepam is combined with thiamylal.


The risk or severity of adverse effects can be increased when Icatibant is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Riociguat.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with halothane.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Normethadone.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when butorphanol is combined with ketamine.


The risk or severity of adverse effects can be increased when diazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with perphenazine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with levorphanol.


The risk or severity of adverse effects can be increased when methocarbamol is combined with nefazodone.